For in vivo tracking, human CD8+ T cells were labeled with XenoLight DiR (Caliper Life Sciences, Hopkinton, USA), and then, these DiR-labeled cells were adoptively transferred into tumor-bearing mice via intravenous injection. Here, CD8A is linked to neoplasm.